arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Trevi Therapeutics, Inc.

TRVI Health Care Biotechnology: Pharmaceutical Preparations
$12.94
▲ +0.9% Today
as of Oct 22, 16:53 ET
Last 30 days -18.57% Sep 14 → Oct 22
$11.56 $12.72 $13.89 $15.05 $16.21 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$12.77
High
$13.22
Low
$12.53
Volume
$1M
Avg Vol
$2M
Mkt Cap
$2.0B
P/E (TTM)
—
Beta
—
52w High
$20.22
52w Low
$9.82
Div Yield
—
Shares Out
$142M

Recent Press Releases & News last 60 days · 7 items

Oct 13 · 22:14 Simply Wall St.
Do Trevi Therapeutics’ (TRVI) CORAL Data and GSK’s Exit Reframe Its Chronic Cough Ambitions?
Oct 13 · 11:30 PR GlobeNewswire
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
Sep 25 · 17:51 MT Newswires
Trevi Therapeutics' Sample Size Re-estimation for Chronic Cough Trial Likely Positive, Oppenheimer Says
▸ Show all 7 press releases & news Free account →

TRVI earnings at a glance

The options market is pricing a move of about ±5.7% after the report, a range of roughly $12.21 to $13.67 from today's $12.94. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±1.4% on average; after the most recent report on May 5, 2026 it moved +1.9%. That means options currently expect more movement than TRVI has typically delivered. TRVI beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 48%. The share price of $12.94 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$9.82
$20
30% of range
Avg surprise (last 4)
+8.1%
Avg reaction (last 2)
+0.5%
50% positive
Latest IV / EM
48%
EM ±5.7% · $13 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.63$-0.36$-0.09$0.17$0.44 Actual $-0.06Actual $-0.07Actual $-0.08Actual $-0.11Actual $-0.12Actual $-0.13Actual $-0.09Est $-0.13Actual $-0.09Est $-0.10Actual $-0.08Est $-0.10Actual $-0.09Est $-0.07Actual $-0.11 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-18M$-16M$-14M$-13M$-11M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.11 — — — — financials
Tue May 5, 2026Mar/2026 $-0.09 $-0.07 -28.6% 0.0% +1.9% earnings
Thu Nov 13, 2025Sep/2025 $-0.08 $-0.10 +20.0% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.09 $-0.10 +10.0% — — earnings
Thu May 8, 2025Mar/2025 $-0.09 $-0.13 +30.8% — -0.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.13 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.12 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.11 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.08 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.07 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.06 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-21M$-15M—$-14M$-14M$-11M—$-14M
Net income$-18M$-13M—$-12M$-12M$-10M—$-13M
EPS (diluted)$-0.11$-0.09—$-0.08$-0.09$-0.09—$-0.13

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$54M$19M$19M$57M$117M$19M$34M$16M
Inventory————————
Total current assets$326M$176M$192M$198M$207M$106M$109M$67M
Total assets$331M$180M$193M$199M$208M$107M$111M$69M
Long-term debt————————
Total liabilities$9M$7M$10M$10M$10M$8M$11M$10M
Total equity$322M$172M$183M$190M$198M$99M$100M$59M

Implied volatility — last 90 days

35%160%285%410%535% Jun 09 — IV 76% · EM ±9.6%Jun 10 — IV 104% · EM ±12.3%Jun 11 — IV 37% · EM ±4.1%Jun 12 — IV 79% · EM ±8.1%Jun 16 — IV 148% · EM ±8.8%Jun 19 — IV 57% · EM ±12.6%Jun 22 — IV 58% · EM ±12.0%Jun 23 — IV 65% · EM ±13.2%Jun 24 — IV 52% · EM ±10.4%Jun 25 — IV 77% · EM ±15.1%Jun 26 — IV 50% · EM ±9.6%Jun 29 — IV 65% · EM ±11.6%Jun 30 — IV 58% · EM ±9.9%Jul 01 — IV 68% · EM ±11.4%Jul 02 — IV 54% · EM ±8.8%Jul 03 — IV 56% · EM ±8.8%Jul 06 — IV 78% · EM ±10.9%Jul 07 — IV 44% · EM ±5.8%Jul 08 — IV 78% · EM ±9.7%Jul 09 — IV 90% · EM ±10.6%Jul 13 — IV 51% · EM ±4.2%Jul 14 — IV 154% · EM ±11.2%Jul 15 — IV 215% · EM ±12.7%Jul 20 — IV 61% · EM ±14.3%Jul 21 — IV 73% · EM ±16.9%Jul 22 — IV 58% · EM ±13.2%Jul 23 — IV 83% · EM ±18.6%Jul 24 — IV 48% · EM ±10.6%Jul 27 — IV 65% · EM ±13.5%Jul 28 — IV 64% · EM ±13.0%Jul 29 — IV 87% · EM ±17.4%Aug 03 — IV 54% · EM ±9.5%Aug 06 — IV 38% · EM ±6.2%Aug 10 — IV 55% · EM ±7.6%Aug 11 — IV 56% · EM ±7.3%Aug 13 — IV 42% · EM ±5.0%Aug 14 — IV 123% · EM ±13.5%Aug 24 — IV 47% · EM ±9.8%Aug 25 — IV 46% · EM ±9.5%Aug 26 — IV 46% · EM ±9.2%Aug 27 — IV 45% · EM ±8.8%Aug 28 — IV 45% · EM ±8.5%Aug 31 — IV 47% · EM ±8.3%Sep 01 — IV 47% · EM ±8.1%Sep 02 — IV 43% · EM ±7.2%Sep 03 — IV 35% · EM ±5.7%Sep 04 — IV 44% · EM ±6.8%Sep 07 — IV 49% · EM ±6.8%Sep 08 — IV 48% · EM ±6.4%Sep 09 — IV 50% · EM ±6.3%Sep 10 — IV 40% · EM ±4.7%Sep 11 — IV 43% · EM ±4.7%Sep 14 — IV 49% · EM ±4.1%Sep 17 — IV 536% · EM ±22.4%Sep 21 — IV 45% · EM ±9.4%Sep 22 — IV 45% · EM ±9.2%Sep 23 — IV 45% · EM ±9.0%Sep 24 — IV 45% · EM ±8.9%Sep 25 — IV 54% · EM ±10.4%Sep 28 — IV 65% · EM ±11.5%Sep 29 — IV 64% · EM ±11.1%Sep 30 — IV 61% · EM ±10.1%Oct 01 — IV 52% · EM ±8.5%Oct 02 — IV 41% · EM ±6.5%Oct 06 — IV 47% · EM ±6.3%Oct 07 — IV 46% · EM ±5.7%Oct 08 — IV 48% · EM ±5.7%

Sector peers

HCM
HUTCHMED (China) Limited
$2.0B $14.28-3.1%
MRVI
Maravai LifeSciences Holdings, Inc.
$1.9B $7.07-1.8%
GPCR
Structure Therapeutics Inc.
$1.9B $21.93-4.2%
AGIO
Agios Pharmaceuticals, Inc.
$1.9B $37.19+1.5%
LKFT
Lakefront Biotherapeutics
$1.9B $31.40+2.1%
XNCR
Xencor, Inc.
$1.8B $25.84+3.6%

TRVI earnings FAQ

What is TRVI's expected move for earnings?

Options currently price a move of about ±5.7%, or $0.73 per share either way from $12.94.

How does TRVI stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.4%, up 1 times and down 1 times.

What is TRVI's implied volatility?

TRVI's at-the-money implied volatility is about 48% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in